These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17970887)

  • 21. The potential use of methotrexate in the treatment of falciparum malaria: in vitro assays against sensitive and multidrug-resistant falciparum strains.
    Dar O; Khan MS; Adagu I
    Jpn J Infect Dis; 2008 May; 61(3):210-1. PubMed ID: 18503171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms underlying methotrexate-induced pulmonary toxicity.
    Kim YJ; Song M; Ryu JC
    Expert Opin Drug Saf; 2009 Jul; 8(4):451-8. PubMed ID: 19538103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Correct use of methotrexate].
    Verduijn MM; van den Bemt BJ; Dijkmans BA; van der Waal RI; Horikx A
    Ned Tijdschr Geneeskd; 2009; 153():A696. PubMed ID: 19785852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic drug-drug interactions with methotrexate in oncology.
    Levêque D; Santucci R; Gourieux B; Herbrecht R
    Expert Rev Clin Pharmacol; 2011 Nov; 4(6):743-50. PubMed ID: 22111860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver biopsy in patients without psoriasis receiving methotrexate: what guidelines are medical dermatologists following?
    Larson MJ; Costner MI
    J Am Acad Dermatol; 2004 Jun; 50(6):e11. PubMed ID: 15153917
    [No Abstract]   [Full Text] [Related]  

  • 26. Oral methotrexate: preventing avoidable overdose.
    Prescrire Int; 2007 Aug; 16(90):150-2. PubMed ID: 17724841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methotrexate pharmacokinetics in transgenic mice with liver-specific expression of human organic anion-transporting polypeptide 1B1 (SLCO1B1).
    van de Steeg E; van der Kruijssen CM; Wagenaar E; Burggraaff JE; Mesman E; Kenworthy KE; Schinkel AH
    Drug Metab Dispos; 2009 Feb; 37(2):277-81. PubMed ID: 19022939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Methotrexate in therapeutical experiments at the Department of Dermatology in Poznan].
    Rosner J; Peisert E
    Przegl Dermatol; 1974; 61(5):613-9. PubMed ID: 4420897
    [No Abstract]   [Full Text] [Related]  

  • 29. Hormesis [biological effects of low-level exposure (B.E.L.L.E.)] and dermatology.
    Thong HY; Maibach HI
    Cutan Ocul Toxicol; 2007; 26(4):329-41. PubMed ID: 18058307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methotrexate Monitoring in Dermatology- A Retrospective Cohort Study.
    Zufall AG; Rama B; Ninmer EK; Vittitow SL; Saito M; Noland MM; Flowers RH
    J Drugs Dermatol; 2021 Mar; 20(3):320-325. PubMed ID: 33683085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema.
    Zoller L; Ramon M; Bergman R
    Isr Med Assoc J; 2008 Jun; 10(6):413-4. PubMed ID: 18669134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug monitoring in inflammatory bowel disease: helpful or dispensable?
    Bruns T; Stallmach A
    Dig Dis; 2009; 27(3):394-403. PubMed ID: 19786771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potassium iodide in dermatology: a 19th century drug for the 21st century-uses, pharmacology, adverse effects, and contraindications.
    Sterling JB; Heymann WR
    J Am Acad Dermatol; 2000 Oct; 43(4):691-7. PubMed ID: 11004629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Off-label uses of rituximab in dermatology.
    Carr DR; Heffernan MP
    Dermatol Ther; 2007; 20(4):277-87. PubMed ID: 17970893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral antibiotic drug interactions of clinical significance to dermatologists.
    Del Rosso JQ
    Dermatol Clin; 2009 Jan; 27(1):91-4. PubMed ID: 18984372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An update on methotrexate.
    Braun J; Rau R
    Curr Opin Rheumatol; 2009 May; 21(3):216-23. PubMed ID: 19373092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. British Association of Dermatologists' guidelines for the safe and effective prescribing of methotrexate for skin disease 2016.
    Warren RB; Weatherhead SC; Smith CH; Exton LS; Mohd Mustapa MF; Kirby B; Yesudian PD
    Br J Dermatol; 2016 Jul; 175(1):23-44. PubMed ID: 27484275
    [No Abstract]   [Full Text] [Related]  

  • 38. Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
    Lindsay K; Fraser AD; Layton A; Goodfield M; Gruss H; Gough A
    Rheumatology (Oxford); 2009 May; 48(5):569-72. PubMed ID: 19273538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methotrexate: clinical pharmacology, current status and therapeutic guidelines.
    Bleyer WA
    Cancer Treat Rev; 1977 Jun; 4(2):87-101. PubMed ID: 329989
    [No Abstract]   [Full Text] [Related]  

  • 40. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.